South San Francisco, CA, United States of America

Vickie Hsiao-Wei Tsui

This inventor holds 26 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 16 EPO patents, primarily in Therapeutic Compounds. Top assignees: Genentech, Inc., Constellation Pharmaceuticals, Inc., F. Hoffmann-La Roche Ag. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vickie Hsiao-Wei Tsui. Retrieved from https://idiyas.com/inventor/vickie-hsiao-wei-tsui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 80.8

 

 

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 206(Granted Patents)


Location History:

  • San Francisco, CA (US) (2007 - 2013)
  • South San Francisco, CA (US) (2016 - 2022)
  • Burlingame, CA (US) (2012 - 2024)

Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
IAP Inhibitors
Therapeutic Compounds
Pyrazolo Compounds
Histone Demethylase Inhibitors
Pyrrolidine Inhibitors
Janus Kinase Inhibitors
Azabicyclo-octane
Compounds
Methods of Use
Inhibitors
Therapeutics
26 patents (USPTO):Explore Patents

Title: Vickie Hsiao-Wei Tsui: Pioneering Therapeutic Innovations

Introduction: Vickie Hsiao-Wei Tsui, based in South San Francisco, CA, is an accomplished inventor and researcher known for her significant contributions to the field of therapeutic agents. With an impressive portfolio of 26 patents, Vickie's work primarily focuses on developing innovative compounds for treating malignancies and various disorders.

Latest Patents: Among her latest patents, Vickie has developed novel inhibitors of IAP that are promising therapeutic agents for malignancies. These inhibitors possess a general formula that includes distinct functional groups, detailed as R, R, R, R, and further specifications. One of her other noteworthy inventions involves a compound formula that targets CBP and/or EP300, showcasing the potential to treat disorders mediated by these proteins. This patent also covers pharmaceutical compositions that incorporate her innovative compounds, providing vital methods for application in medical treatments.

Career Highlights: Vickie's career has been marked by her collaborations with renowned companies in the pharmaceutical field, including Genentech, Inc. and Constellation Pharmaceuticals, Inc. Her work in these companies has not only allowed her to bring her innovative ideas to fruition but has also positioned her prominently in the realm of biotechnology.

Collaborations: Throughout her career, Vickie has collaborated with esteemed colleagues such as Steven R Magnuson and Frederick Cohen. These collaborations have enriched her research and contributed to her success in patenting her inventions, reflecting the power of teamwork in advancing scientific discovery.

Conclusion: Vickie Hsiao-Wei Tsui stands out as a trailblazer in the field of therapeutic innovations. Her commitment to advancing medical science through her patents and collaborative efforts has cemented her status as a leading inventor in the biotech industry. With her ongoing contributions, Vickie continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…